Search

You searched for "invasive"

366 results found

Inguino-scrotal sarcomas

1 May 2019 | | URO - Uroradiology, URO - Urologic Oncology, URO - Andrology
A sarcoma is a malignant tumour that originates from mesenchymal cells such as adipose tissue, bone, cartilage and smooth muscle. Although these tumours histologically do not originate from the urogenital tract, urologists are often involved in their diagnosis and management...

Intravesical GAG replacement therapies for bladder pain syndrome / interstitial cystitis – an update

4 May 2020 | | URO - Functional / Reconstructive Urology, URO - Infection, URO - Basic Science Research
The barrier function of the glycosaminoglycan (GAG) layer of the urothelium was identified by Parsons in 1975, and intravesical therapies to treat chronic inflammatory conditions of the bladder were developed soon after. However, the active role of the urothelium in...
European Urology journal cover image

One cycle of adjuvant chemotherapy in tumours of the testis

4 May 2020 | | URO - Urologic Oncology
Following a radical orchiectomy, current UK practice for newly diagnosed, high-risk, stage 1 nonseminomatous or combined germ cell tumours of the testis (NSCGCTT) is either two cycles of adjuvant chemotherapy with bleomycin, etoposide, cisplatin (BE360Px2) or surveillance with BE500Px3 on...

Urinary incontinence in women – part 2: management

1 September 2015 | | URO - Functional / Reconstructive Urology
In the second part of our comprehensive overview of urinary incontinence (UI) the authors explore the plethora of treatment options for this complex condition. (Part 1 available here). Conservative management Initial treatment of incontinence should be conservative. Caffeine reduction and...

In conversation with Ian Pearce

21 August 2024 | URO - Core Urology
We were delighted to catch up with our old friend, Ian Pearce, former Editor of Urology News and new President of BAUS. Can you tell us a little bit about what led you into the field of urology and the...

APCCC (Advanced Prostate Cancer Consensus Conference) Diagnostics 2025

27 February 2025 -28 February 2025
The diagnostic abilities for assessing prostate cancer patients have significantly evolved in the last years. Ranging from advanced imaging modalities for detection, new innovative liquid and tissue based biomarkers as well as the recent introduction of PSMA PET imaging have significantly advanced the field, challenging some of the old grounds of truth.

AUA (American Urological Association) Annual Meeting 2025

26 April 2025 -29 April 2025
The American Urological Association (AUA) continues to be a leader in developing innovative, evidence-based quality education for urologists and urologic health care professionals worldwide. Through the Annual Meeting—and other year-round educational offerings—the AUA sets the highest standards for urologic education.

RSM (Royal Society of Medicine) Inspiration Care in Urology

27 March 2026
Following the success of the 2024 event, this second edition will spotlight innovative treatment pathways and models of care being implemented across the UK. Expect practical insights and inspiring stories from leaders in urological service delivery.

LUTS update

8 January 2024 | | URO - Functional / Reconstructive Urology
Case study A 70-year-old, generally fit and well male attends your outpatient clinic. He has experienced a gradual deterioration in his voiding over the last few months. Specifically, he reports hesitancy, poor flow and nocturia. He denies visible haematuria. His...

Non-urothelial bladder malignancies

3 May 2024 | | URO - Urologic Oncology
Case 1 An 80-year-old gentleman presented with a history of visible haematuria and recurrent urinary tract infections (UTIs). He has been performing intermittent self catheterisation (ISC) for detrusor underactivity for over 20 years. A flexible cystoscopy showed these appearances of...

Virtual reality: a novel approach to pain management during ESWL

4 March 2025 | | URO - Technology, URO - Endourology & Stones
Extracorporeal shock wave lithotripsy (ESWL) is a well-established treatment for kidney and ureteric stone disease, employing high-energy shock waves to fragment stones into smaller pieces for passage through the urinary tract. This article explores the application of virtual reality (VR)...

Modern management of small renal masses

1 September 2019 | | URO - Urologic Oncology
With the advent of widespread cross-sectional imaging there has been a surge in incidental detection of small renal masses (SRMs) and renal cell carcinoma (RCC) is now the seventh most common cancer in the UK. Whilst surgical excision for larger...